The Circadian Diet in Age-Related Neurodegeneration: Nutrient Timing, Sleep, and Mitochondrial Mechanisms
- 1Department of Biochemistry, Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 020956 Bucharest, Romania
- 2Department of Physics and Informatics, Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 020956 Bucharest, Romania
Abstract
Circadian rhythms coordinate sleep–wake regulation, endocrine secretion, nutrient handling and cellular energy metabolism. Circadian and sleep disturbances are associated with metabolic and cardiovascular morbidity and with neurodegenerative disorders, particularly Alzheimer’s disease (AD) and Parkinson’s disease (PD), although whether restoring circadian alignment modifies neurodegeneration remains uncertain. This narrative review examines chrononutrition within the broader context of sleep regulation, physical activity and circadian care, distinguishing evidence from cellular and animal models, observational studies and clinical trials. Meal timing and dietary composition act as signals to peripheral clocks, while NAD+, sirtuins and AMP-activated protein kinase link nutrient availability with clock regulation and mitochondrial metabolism. We appraise time-restricted eating, protein distribution, NAD+ precursors, tryptophan- and melatonin-containing foods, magnesium, omega-3 fatty acids, polyphenols and fermentable fiber. Experimental findings provide mechanistic plausibility, but metabolic improvements and target engagement have not translated into demonstrated neuroprotection. Clinical application must account for levodopa–protein interactions, undernutrition, frailty and sarcopenia. Adequately powered trials with circadian-phase assessment, controlled energy intake and clinically meaningful neurological outcomes are required before a “circadian diet” can be established as a disease-modifying intervention.
Related
- Role of Leu and Val synthesis in sensing mitochondrial nutrient and energy availability
- AKAP1 Protects Retinal Ganglion Cells and Preserves Vision by Improving Mitochondrial and Synaptic Health in Glaucomatous Neurodegeneration.
- Association of triglyceride-glucose and its related indices with circadian syndrome : Evidence from a prospective cohort study
- Cancer cells differentially modulate mitochondrial respiration to alter redox state and enable biomass synthesis in nutrient-limited environments
- Circadian rhythm dysregulation and ferroptosis in hypertension: mechanisms and therapeutic implications
BibTeX
@article{dragoi2026circadian,
title = {{The Circadian Diet in Age-Related Neurodegeneration: Nutrient Timing, Sleep, and Mitochondrial Mechanisms}},
author = {Cristina Manuela Drăgoi and Alina-Crenguţa Nicolae and Ion-Bogdan Dumitrescu},
journal = {Nutrients},
year = {2026},
month = nov,
doi = {10.3390/nu18213682},
url = {https://www.mdpi.com/2072-6643/18/21/3682},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The Circadian Diet in Age-Related Neurodegeneration: Nutrient Timing, Sleep, and Mitochondrial Mechanisms
AU - Cristina Manuela Drăgoi
AU - Alina-Crenguţa Nicolae
AU - Ion-Bogdan Dumitrescu
PY - 2026
DA - 2026/11/06
JO - Nutrients
DO - 10.3390/nu18213682
UR - https://www.mdpi.com/2072-6643/18/21/3682
AB - Circadian rhythms coordinate sleep–wake regulation, endocrine secretion, nutrient handling and cellular energy metabolism. Circadian and sleep disturbances are associated with metabolic and cardiovascular morbidity and with neurodegenerative disorders, particularly Alzheimer’s disease (AD) and Parkinson’s disease (PD), although whether restoring circadian alignment modifies neurodegeneration remains uncertain. This narrative review examines chrononutrition within the broader context of sleep regulation, physical activity and circadian care, distinguishing evidence from cellular and animal models, observational studies and clinical trials. Meal timing and dietary composition act as signals to peripheral clocks, while NAD+, sirtuins and AMP-activated protein kinase link nutrient availability with clock regulation and mitochondrial metabolism. We appraise time-restricted eating, protein distribution, NAD+ precursors, tryptophan- and melatonin-containing foods, magnesium, omega-3 fatty acids, polyphenols and fermentable fiber. Experimental findings provide mechanistic plausibility, but metabolic improvements and target engagement have not translated into demonstrated neuroprotection. Clinical application must account for levodopa–protein interactions, undernutrition, frailty and sarcopenia. Adequately powered trials with circadian-phase assessment, controlled energy intake and clinically meaningful neurological outcomes are required before a “circadian diet” can be established as a disease-modifying intervention.
SN - 2072-6643
ER -